NNC0638-0355

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0638-0355, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity [Phase 1]